Abstract
Significance
We evaluated weight loss outcomes in a newly established hospital-affiliated, physician-directed multidisciplinary, and personalized obesity care model.
Methods
Fifty established patients in a specialized obesity medicine practice underwent intensive lifestyle intervention ±adjunctive pharmacotherapy (46/50) for >6 consecutive months and when required, psychological intervention. We identified demographics, obesity-related comorbidities, anthropometric changes over time, and laboratory screen. Psychosocial status was determined using Beck Depression Inventory-II (BDI-II), Brownell-Stunkard Weight-Loss Readiness Test, and Impact of Weight on Quality of Life-Lite (IWQOL).
Results
Patient characteristics (mean ± SD) were: 70% female; age 47.0 ± 16.4 y; weight 111.55 ± 32.8 kg; BMI 39.3 ± 8.8 kg/m2; % body fat 45.5 ± 6.3. Patients had attempted at least one diet prior to seeking tertiary obesity care and averaged 2.5 major co-morbidities. In regards to health status, 74% were insulin resistant [HOMA]; 12% had Type 2 DM (HbA1c > 6.5%); 46% were hypertensive; 48% had dyslipidemia, 38% were vitamin D deficient; 44% were depressed (BDI-II). Weight loss at 3 and 6 months averaged −4.18 and −7.88 kg and percentage changes in BMI a respective −4.39 and −7.74% (p < 0.0001). Forty percentage were early responders (ER), having lost ≥ 5% of their initial weight 3 months into the program. Total weight loss for ER vs. non-responders (NR) at 3 months was −7.90 and −1.71 kg, respectively (p < 0.0001) and mean % BMI changes from baseline were a respective −7.77 and −1.88%.
Conclusions
Organized hospital-affiliated specialized obesity care delivery models can be successful in personalized obesity treatment. These types of medical programs for complicated obesity are likely to reduce impediments to addressing obesity effectively.
Similar content being viewed by others
References
Baum C, Andino K, Wittbrodt E, Stewart S, Szymanski K, Turpin R. The challenges and opportunities associated with reimbursement for obesity pharmacotherapy in the USA. Pharmacoeconomics. 2015;33:643–53.
Srivastava G, Apovian CM. Current pharmacotherapy for obesity. Nat Rev Endocrinol. 2017;14:12–24.
Sebiany AM. Primary care physicians’ knowledge and perceived barriers in the management of overweight and obesity. J Fam Community Med. 2013;20:147–52.
Bleich SN, Bandara S, Bennett WL, Cooper LA, Gudzune KA, U.S. health professionals’ views on obesity care, training, and self-efficacy. Am J Prev Med. 2015;48:411–8.
Mauro M, Taylor V, Wharton S, Sharma AM. Barriers to obesity treatment. Eur J Intern Med. 2008;19:173–80.
Glauser TA, Roepke N, Stevenin B, Dubois AM, Ahn SM. Physician knowledge about and perceptions of obesity management. Obes Res Clin Pract. 2015;9:573–83.
Bennett GG, Steinberg DM, Pagoto SL. Will obesity treatment reimbursement benefit those at highest risk? Am J Med. 2015;128:670–1.
Lee BY, Bartsch SM, Mui Y, Haidari LA, Spiker ML, Gittelsohn J. A systems approach to obesity. Nutr Rev. 2017;75(suppl 1):94–106.
Wiebe JS, Penley JA. A psychometric comparison of the Beck Depression Inventory-II in English and Spanish. Psychol Assess. 2005;17:481–5.
Carlson S, Sonnenberg LM, Cummings S. Dieting readiness test predicts completion in a short-term weight loss program. J Am Diet Assoc. 1994;94:552–4.
Kolotkin RL, Head S, Hamilton M, Tse CK. Assessing impact of weight on quality of life. Obes Res. 1995;3:49–56.
Unick JL, Pellegrini CA, Demos KE, Dorfman L. Initial weight loss response as an indicator for providing early rescue efforts to improve long-term treatment outcomes. Curr Diab Rep. 2017;17:69.
Geha P, Cecchi G, Todd Constable R, Abdallah C, Small DM. Reorganization of brain connectivity in obesity. Hum Brain Mapp. 2017;38:1403–20.
Jones A, Hardman CA, Lawrence N, Field M. Cognitive training as a potential treatment for overweight and obesity: a critical review of the evidence. Appetite. 2017;124:50–67.
Garfinkel BP, Hotamisligil GS. ER stress promotes inflammation through re-wired macrophages in obesity. Mol Cell. 2017;66:731–3.
Ellulu MS, Patimah I, Khaza’ai H, Rahmat A, Abed Y. Obesity and inflammation: the linking mechanism and the complications. Arch Med Sci. 2017;13:851–63.
Asghar A, Sheikh N. Role of immune cells in obesity induced low grade inflammation and insulin resistance. Cell Immunol. 2017;315:18–26.
Koch CE, Leinweber B, Drengberg BC, Blaum C, Oster H. Interaction between circadian rhythms and stress. Neurobiol Stress. 2017;6:57–67.
Presson AP, Zhang C, Abtahi AM, Kean J, Hung M, Tyser AR. Psychometric properties of the Press Ganey(R) Outpatient Medical Practice Survey. Health Qual Life Outcomes. 2017;15:32.
Spring B, Sohn MW, Locatelli SM, Hadi S, Kahwati L, Weaver FM. Individual, facility, and program factors affecting retention in a national weight management program. BMC Public Health. 2014;14:363.
Hadziabdic MO, Mucalo I, Hrabac P, Matic T, Rahelic D, Bozikov V. Factors predictive of drop-out and weight loss success in weight management of obese patients. J Hum Nutr Diet. 2015;28(Suppl 2):24–32.
Teixeira PJ, Going SB, Houtkooper LB, Cussler EC, Metcalfe LL, Blew RM, et al. Pretreatment predictors of attrition and successful weight management in women. Int J Obes Relat Metab Disord. 2004;28:1124–33.
Acknowledgements
The authors would like to thank the exemplary, dedicated clinical team at COM including the clinical Lifestyle team that was co-founded with COM for administrative support. We thank Florida Hospital Medical Group for their keen business insights and the Translational Research Institute in Orlando, FL for mentorship and support in the establishment of an obesity clinical infrastructure. We would also like to thank Monica Reed, MD former CEO of Celebration Health, who was present during the implementation phase of COM and initial year, whose unrelenting support and understanding for a comprehensive wellness and obesity program brought COM to life. Finally, we are grateful to all of our patients suffering with obesity who found COM to be their medical home.
Author contributions
GS conceptualized and designed the clinical infrastructure for COM during the implementation phase. GS collected de-identified data, analyzed, and interpreted the results and wrote the content of the manuscript. CB gave valuable research insights when designing COM. CB provided critical statistical analyses and edited the content of the manuscript.
Funding
No funding was provided for this study. GS serves as a consultant for Johnson and Johnson. GS was the Founder of the Center for Obesity Medicine (COM).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Srivastava, G., Buffington, C. Early weight loss outcomes from a newly established hospital-affiliated specialized obesity care delivery model in Central Florida. Int J Obes 43, 132–138 (2019). https://doi.org/10.1038/s41366-018-0092-3
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41366-018-0092-3
- Springer Nature Limited